Apimeds US board and CEO ousted; new board approves expansion into Korean cosmetics and photo booth

Apimeds Pharmaceuticals US, Inc.

Majority stockholders removed directors Elona Kogan, Jakap Koo, Carol O’Donnell, Dr. Bennett Weintraub via written consent.
CEO Vin Menon and CFO Erick Frim removed; Youngjik Cho appointed CEO, Junyoung Yu as Secretary.
New board approved non-binding MOUs with Assemble, Hilluck (cosmetics distribution) and LK Ventures (Life4Cuts photo booth platform).
Company delays previously announced 1-for-10 reverse stock split; board will continue to evaluate timing.
MindWave issued unauthorized press release challenging the consent; company intends to vigorously defend validity.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Apimeds Pharmaceuticals US, Inc.: Amended bylaws to allow majority voting power to fill board vacancies and to confirm amendments may be approved by majority voting power (effective 2026-03-20).

Change: bylaw amendment
Effective: 2026-03-20

Exact text from the filing

Pursuant to the Consent, the Majority Stockholders also amended the Amended and Restated Bylaws of the Company, as amended to date, to (a) allow stockholders of the Company holding a majority of the voting power of the Company the power to fill vacancies on the Board and (b) confirm that amendments to the Company’s bylaws may be approved by a majority of the voting power of the Company.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Apimeds Pharmaceuticals US, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-033832

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.